GRACE is excited to bring to our Spanish speaking community - Cancer Basics Dr. Duma is an Assistant Professor and Thoracic Oncologist at @UWcarbone...
VIDEOS
GRACE is excited to bring you new information in our Bladder Cancer Program, hosted by Ramy Sedhom, MD. For this first video of 2019, Dr. Ramy Sedhom...
GRACE is very excited to bring you more of our program on supportive care in cancer treatment. Arjun Gupta, MD, one of the GRACE Fellows Ambassador...
We are very excited to bring to you more information through our new program regarding supportive care in cancer treatment. Arjun Gupta, MD, one of...
We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor...
ARTICLES
As we learn more about immunotherapy for lung cancer, combinations with multiple immunotherapy agents are being explored. Medical oncologist Dr. Eddie Garon considers whether combinations are likely to emerge as the leading immunotherapy approach.
Drs. Leora Horn, Ben Solomon, & Jack West consider whether third generation EGFR TKIs, so active in patients with acquired resistance, might be best used prior to development of acquired resistance.
“Gratitude is one of the most medicinal emotions we can feel.” (Sara Avant Stover) Thank you for joining GRACE in our #LCAM15 activities.
Dr. Jack West reviews the Lung Cancer Master Protocol for second line treatment of patients with advanced squamous NSCLC, an "umbrella protocol" in which all patients undergo molecular testing and have treatment assigned by the results.
Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.